News Life and Health10 Jan 2023

China:Bid to add Paxlovid to national drug reimbursement list fails

10 Jan 2023

China's healthcare authorities have declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.

Archived articles are available to Magazine subscribers only.

If you are already a subscriber

OR sign-up for a trial access here

For Full Access to the magazine SUBSCRIBE here.
CAPTCHA image
Enter the code shown above in the box below.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

 
Error : Object reference not set to an instance of an object.

Recent Comments
Other News

Follow Asia Insurance Review